Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry.
Goldhaber SZ, Bassand JP, Camm AJ, Virdone S, Pieper K, Cools F, Corbalan R, Gersh BJ, Goto S, Haas S, Misselwitz F, Parkhomenko A, Steffel J, Stepinska J, Turpie AGG, Verheugt FWA, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Goldhaber SZ, et al. Among authors: corbalan r. Am J Med. 2024 Feb;137(2):128-136.e13. doi: 10.1016/j.amjmed.2023.10.027. Epub 2023 Oct 31. Am J Med. 2024. PMID: 37918777 Free article.
Targeting VCAM-1: a therapeutic opportunity for vascular damage.
Troncoso MF, Díaz-Vesga MC, Sanhueza-Olivares F, Riquelme JA, Müller M, Garrido L, Gabrielli L, Chiong M, Corbalan R, Castro PF, Lavandero S. Troncoso MF, et al. Among authors: corbalan r. Expert Opin Ther Targets. 2023 Mar;27(3):207-223. doi: 10.1080/14728222.2023.2187778. Epub 2023 Mar 15. Expert Opin Ther Targets. 2023. PMID: 36880349
Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study.
Felker GM, Solomon SD, Metra M, Mcmurray JJV, Diaz R, Claggett B, Lanfear DE, Vandekerckhove H, Biering-Sørensen T, Lopes RD, Arias-Mendoza A, Momomura SI, Corbalan R, Ramires FJA, Zannad F, Heitner SB, Divanji PH, Kupfer S, Malik FI, Teerlink JR. Felker GM, et al. Among authors: corbalan r. J Card Fail. 2024 Jun;30(6):755-763. doi: 10.1016/j.cardfail.2023.11.021. Epub 2024 Jan 11. J Card Fail. 2024. PMID: 38215932 Free article. Clinical Trial.
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
Gliflozins and Atrial Fibrillation.
Corbalan R, Acevedo M. Corbalan R, et al. J Am Coll Cardiol. 2022 Nov 1;80(18):1718-1720. doi: 10.1016/j.jacc.2022.08.746. Epub 2022 Aug 27. J Am Coll Cardiol. 2022. PMID: 36041670 Free article. No abstract available.
Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial.
Solomon SD, Claggett BL, Miao ZM, Diaz R, Felker GM, McMurray JJV, Metra M, Corbalan R, Filippatos G, Goudev AR, Mareev V, Serpytis P, Suter T, Yilmaz MB, Zannad F, Kupfer S, Heitner SB, Malik FI, Teerlink JR. Solomon SD, et al. Among authors: corbalan r. Eur Heart J. 2022 Jun 14;43(23):2212-2220. doi: 10.1093/eurheartj/ehac144. Eur Heart J. 2022. PMID: 35325102 Clinical Trial.
VCAM-1 as a predictor biomarker in cardiovascular disease.
Troncoso MF, Ortiz-Quintero J, Garrido-Moreno V, Sanhueza-Olivares F, Guerrero-Moncayo A, Chiong M, Castro PF, García L, Gabrielli L, Corbalán R, Garrido-Olivares L, Lavandero S. Troncoso MF, et al. Among authors: corbalan r. Biochim Biophys Acta Mol Basis Dis. 2021 Sep 1;1867(9):166170. doi: 10.1016/j.bbadis.2021.166170. Epub 2021 May 14. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 34000374 Free article. Review.
282 results